OptiNose, Inc. (NASDAQ: OPTN) had its price target lowered by analysts at Lake Street Capital from $4.00 to $3.00. They now have a "buy" rating on the stock.
OptiNose, Inc. (OPTN)
Last optinose, inc. earnings: 3/5 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.optinose.com
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
OPTN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPTN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPTN alerts
High impacting OptiNose, Inc. news events
Weekly update
A roundup of the hottest topics
OPTN
News
- Positive week for OptiNose, Inc. (NASDAQ:OPTN) institutional investors who lost 24% over the past year [Yahoo! Finance]Yahoo! Finance
- Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Optinose Appoints Terry Kohler as Chief Financial OfficerGlobeNewswire
- OptiNose (NASDAQ:OPTN) shareholders have endured a 88% loss from investing in the stock five years ago [Yahoo! Finance]Yahoo! Finance
- New Peer-Reviewed Data Highlight the Benefits of XHANCE in Chronic Rhinosinusitis Patients with or without Prior Sinus SurgeryGlobeNewswire
OPTN
Earnings
- 8/8/24 - Beat
OPTN
Sec Filings
- 10/18/24 - Form SC
- 10/16/24 - Form 8-K
- 10/8/24 - Form 8-K
- OPTN's page on the SEC website